Paper8551233
Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.
Celluzzi CM and 4 others. J Exp Med, 1996. Cited by 621 papers, by iCite.
Cite this record
ConductScience Library. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. Papers, record 8551233. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8551233
- Cell line
- B16-MO52 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Cell lines1
Source Cell lines
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigen Presentation | Major topic |
| Dendritic Cells | Major topic |
| Immunization | Major topic |
| Neoplasms, Experimental | Major topic |
| Peptide Fragments | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Cytotoxicity, Immunologic | |
| Female | |
| Melanoma, Experimental | |
| Mice | |
| Mice, Inbred BALB C | |
| Molecular Sequence Data | |
| Survival Analysis | |
| Thymoma |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| ARO11884 | NIAMS NIH HHS | United States | PubMed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 8551246 | Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. | https://conductscience.org/library/papers/8551246 |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2224800 | Infiltration of dendritic cells in relation to tumor invasion and lymph node metastasis in human gastric cancer. | Cancer | 1990 | https://conductscience.org/library/papers/2224800 | PubMed |
| 2 | 1460426 | Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. | J Exp Med | 1992 | https://conductscience.org/library/papers/1460426 | PubMed |
| 3 | 2027387 | Peptide binding to empty HLA-B27 molecules of viable human cells. | Nature | 1991 | https://conductscience.org/library/papers/2027387 | PubMed |
| 4 | 1709722 | Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. | Nature | 1991 | https://conductscience.org/library/papers/1709722 | PubMed |
| 5 | 8125131 | Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. | Eur J Immunol | 1994 | https://conductscience.org/library/papers/8125131 | PubMed |
| 6 | 7679411 | Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers. | J Clin Invest | 1993 | https://conductscience.org/library/papers/7679411 | PubMed |
| 7 | 8381832 | Peptide-priming of cytolytic T cell immunity in vivo using beta 2-microglobulin as an adjuvant. | J Immunol | 1993 | https://conductscience.org/library/papers/8381832 | PubMed |
| 8 | 8440919 | Autologous melanoma vaccine induces inflammatory responses in melanoma metastases: relevance to immunologic regression and immunotherapy. | J Invest Dermatol | 1993 | https://conductscience.org/library/papers/8440919 | PubMed |
| 9 | 8453065 | The transporters associated with antigen presentation. | Semin Cell Biol | 1993 | https://conductscience.org/library/papers/8453065 | PubMed |
| 10 | 2152503 | Dendritic cells as antigen presenting cells in vivo. | Int Rev Immunol | 1990 | https://conductscience.org/library/papers/2152503 | PubMed |
| 11 | 8357960 | Dendritic cell activity against primary tumors: an overview. | In Vivo | 1993 | https://conductscience.org/library/papers/8357960 | PubMed |
| 12 | 8379358 | Dendritic cells: antigen presentation, accessory function and clinical relevance. | Adv Exp Med Biol | 1993 | https://conductscience.org/library/papers/8379358 | PubMed |
| 13 | 7506034 | Costimulation of T cells for tumor immunity. | Immunol Today | 1993 | https://conductscience.org/library/papers/7506034 | PubMed |
| 14 | 6395653 | Immunological surveillance of tumors in the context of major histocompatibility complex restriction of T cell function. | Adv Cancer Res | 1984 | https://conductscience.org/library/papers/6395653 | PubMed |
| 15 | 2438367 | Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by class I-restricted cytotoxic T lymphocytes. | J Exp Med | 1987 | https://conductscience.org/library/papers/2438367 | PubMed |
| 16 | 2955069 | Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells. | J Exp Med | 1987 | https://conductscience.org/library/papers/2955069 | PubMed |
| 17 | 2965525 | Perturbation of epidermal Langerhans cells in basal cell carcinomas. | Am J Dermatopathol | 1987 | https://conductscience.org/library/papers/2965525 | PubMed |
| 18 | 3289152 | Prevention of alloantibody formation after skin grafting without prolongation of graft survival by anti-L3T4 in vivo. | Transplantation | 1988 | https://conductscience.org/library/papers/3289152 | PubMed |
| 19 | 3261634 | Introduction of soluble protein into the class I pathway of antigen processing and presentation. | Cell | 1988 | https://conductscience.org/library/papers/3261634 | PubMed |
| 20 | 3264384 | Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. | N Engl J Med | 1988 | https://conductscience.org/library/papers/3264384 | PubMed |
Cited by140
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 621 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42013310 | Intratumoral Sotigalimab with Pembrolizumab Induces Rapid Activation of Antigen-Presenting Cells and Drives Antitumor Responses in Non-injected Tumors in Metastatic Melanoma: A Phase I/II Study. | Cancer Discov | 2026 | https://conductscience.org/library/papers/42013310 | PubMed |
| 40046256 | MHC class I trafficking signal improves induction of cytotoxic T lymphocyte using artificial antigen presenting cells. | Biochem Biophys Rep | 2025 | https://conductscience.org/library/papers/40046256 | PubMed |
| 38781575 | Proteomimetic Polymers Trigger Potent Antigen-Specific T Cell Responses to Limit Tumor Growth. | J Am Chem Soc | 2024 | https://conductscience.org/library/papers/38781575 | PubMed |
| 37798557 | Depletion of slow-cycling PDGFRα+ADAM12+ mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis. | Nat Immunol | 2023 | https://conductscience.org/library/papers/37798557 | PubMed |
| 37419930 | A novel CTLA-4 blocking strategy based on nanobody enhances the activity of dendritic cell vaccine-stimulated antitumor cytotoxic T lymphocytes. | Cell Death Dis | 2023 | https://conductscience.org/library/papers/37419930 | PubMed |
| 37067182 | Melanoma stem cell vaccine induces effective tumor immunity against melanoma. | Hum Vaccin Immunother | 2023 | https://conductscience.org/library/papers/37067182 | PubMed |
| 37008996 | Migration of stem-like CD8 T cells between tissue microenvironments underpins successful anti-tumour immune responses. | Discov Immunol | 2023 | https://conductscience.org/library/papers/37008996 | PubMed |
| 36845151 | Designing neoantigen cancer vaccines, trials, and outcomes. | Front Immunol | 2023 | https://conductscience.org/library/papers/36845151 | PubMed |
| 33197129 | Combining chemotherapy and autologous peptide-pulsed dendritic cells provides survival benefit in stage IV melanoma patients. | J Dtsch Dermatol Ges | 2020 | https://conductscience.org/library/papers/33197129 | PubMed |
| 32368439 | Allogenic γδ T cell and tumor cell fused vaccine for enhanced immunotherapeutic efficacy of osteosarcoma. | J Bone Oncol | 2020 | https://conductscience.org/library/papers/32368439 | PubMed |
| 30166856 | Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer. | World J Gastroenterol | 2018 | https://conductscience.org/library/papers/30166856 | PubMed |
| 30127867 | Antitumor efficacy of the Runx2-dendritic cell vaccine in triple-negative breast cancer in vitro. | Oncol Lett | 2018 | https://conductscience.org/library/papers/30127867 | PubMed |
| 29916701 | Augmenting Vaccine Immunogenicity through the Use of Natural Human Anti-rhamnose Antibodies. | ACS Chem Biol | 2018 | https://conductscience.org/library/papers/29916701 | PubMed |
| 29260582 | Sipuleucel-T for the treatment of prostate cancer: novel insights and future directions. | Future Oncol | 2018 | https://conductscience.org/library/papers/29260582 | PubMed |
| 29104773 | Antitumor Vaccines Based on Dendritic Cells: From Experiments using Animal Tumor Models to Clinical Trials. | Acta Naturae | 2017 | https://conductscience.org/library/papers/29104773 | PubMed |
| 28965431 | Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3. | Expert Rev Clin Immunol | 2017 | https://conductscience.org/library/papers/28965431 | PubMed |
| 28761621 | Toxicity and Immunogenicity in Murine Melanoma following Exposure to Physical Plasma-Derived Oxidants. | Oxid Med Cell Longev | 2017 | https://conductscience.org/library/papers/28761621 | PubMed |
| 28468947 | Phase I Trial of Intratumoral Injection of CCL21 Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8+ T-cell Infiltration. | Clin Cancer Res | 2017 | https://conductscience.org/library/papers/28468947 | PubMed |
| 28358273 | New frontiers in the treatment of colorectal cancer: Autophagy and the unfolded protein response as promising targets. | Autophagy | 2017 | https://conductscience.org/library/papers/28358273 | PubMed |
| 28339788 | Intravenous dendritic cell administration enhances suppression of lung metastasis induced by carbon-ion irradiation. | J Radiat Res | 2017 | https://conductscience.org/library/papers/28339788 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8551233
GET https://conductscience.org/api/papers/v1/8551233/references?page=2